Literature DB >> 28668640

Spectroscopic studies of the cytochrome P450 reaction mechanisms.

Piotr J Mak1, Ilia G Denisov2.   

Abstract

The cytochrome P450 monooxygenases (P450s) are thiolate heme proteins that can, often under physiological conditions, catalyze many distinct oxidative transformations on a wide variety of molecules, including relatively simple alkanes or fatty acids, as well as more complex compounds such as steroids and exogenous pollutants. They perform such impressive chemistry utilizing a sophisticated catalytic cycle that involves a series of consecutive chemical transformations of heme prosthetic group. Each of these steps provides a unique spectral signature that reflects changes in oxidation or spin states, deformation of the porphyrin ring or alteration of dioxygen moieties. For a long time, the focus of cytochrome P450 research was to understand the underlying reaction mechanism of each enzymatic step, with the biggest challenge being identification and characterization of the powerful oxidizing intermediates. Spectroscopic methods, such as electronic absorption (UV-Vis), electron paramagnetic resonance (EPR), nuclear magnetic resonance (NMR), electron nuclear double resonance (ENDOR), Mössbauer, X-ray absorption (XAS), and resonance Raman (rR), have been useful tools in providing multifaceted and detailed mechanistic insights into the biophysics and biochemistry of these fascinating enzymes. The combination of spectroscopic techniques with novel approaches, such as cryoreduction and Nanodisc technology, allowed for generation, trapping and characterizing long sought transient intermediates, a task that has been difficult to achieve using other methods. Results obtained from the UV-Vis, rR and EPR spectroscopies are the main focus of this review, while the remaining spectroscopic techniques are briefly summarized. This article is part of a Special Issue entitled: Cytochrome P450 biodiversity and biotechnology, edited by Erika Plettner, Gianfranco Gilardi, Luet Wong, Vlada Urlacher, Jared Goldstone.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cytochrome P450; EPR spectroscopy; NMR spectroscopy; Nanodiscs; Resonance Raman spectroscopy; UV–Vis spectroscopy

Mesh:

Substances:

Year:  2017        PMID: 28668640      PMCID: PMC5709052          DOI: 10.1016/j.bbapap.2017.06.021

Source DB:  PubMed          Journal:  Biochim Biophys Acta Proteins Proteom        ISSN: 1570-9639            Impact factor:   3.036


  351 in total

1.  EPR spectrometry of cytochrome P450 2B4: effects of mutations and substrate binding.

Authors:  J E LeLean; N Moon; W R Dunham; M J Coon
Journal:  Biochem Biophys Res Commun       Date:  2000-09-24       Impact factor: 3.575

Review 2.  Expanding P450 catalytic reaction space through evolution and engineering.

Authors:  John A McIntosh; Christopher C Farwell; Frances H Arnold
Journal:  Curr Opin Chem Biol       Date:  2014-03-20       Impact factor: 8.822

Review 3.  Mechanistic enzymology of oxygen activation by the cytochromes P450.

Authors:  Thomas M Makris; Roman Davydov; Ilia G Denisov; Brian M Hoffman; Stephen G Sligar
Journal:  Drug Metab Rev       Date:  2002-11       Impact factor: 4.518

4.  Cytochrome P450cam and its complexes. Mössbauer parameters of the heme iron.

Authors:  M Sharrock; P G Debrunner; C Schulz; J D Lipscomb; V Marshall; I C Gunsalus
Journal:  Biochim Biophys Acta       Date:  1976-01-20

5.  Elucidating the role of the proximal cysteine hydrogen-bonding network in ferric cytochrome P450cam and corresponding mutants using magnetic circular dichroism spectroscopy.

Authors:  Mary Grace I Galinato; Tatyana Spolitak; David P Ballou; Nicolai Lehnert
Journal:  Biochemistry       Date:  2011-01-21       Impact factor: 3.162

6.  Cytochrome P450 is present in both ferrous and ferric forms in the resting state within intact Escherichia coli and hepatocytes.

Authors:  Wayne A Johnston; Dominic J B Hunter; Christopher J Noble; Graeme R Hanson; Jeanette E Stok; Martin A Hayes; James J De Voss; Elizabeth M J Gillam
Journal:  J Biol Chem       Date:  2011-10-05       Impact factor: 5.157

7.  Catalytically self-sufficient P450 CYP102 (cytochrome P450 BM-3): resonance Raman spectral characterization of the heme domain and of the holoenzyme.

Authors:  J Hudeèek; V Baumruk; P Anzenbacher; A W Munro
Journal:  Biochem Biophys Res Commun       Date:  1998-02-24       Impact factor: 3.575

8.  Specific effects of potassium ion binding on wild-type and L358P cytochrome P450cam.

Authors:  Bo OuYang; Susan Sondej Pochapsky; Gina M Pagani; Thomas C Pochapsky
Journal:  Biochemistry       Date:  2006-12-05       Impact factor: 3.162

9.  Characterization of stable human aromatase expressed in E. coli.

Authors:  Norio Kagawa; Hiroshi Hori; Michael R Waterman; Shiro Yoshioka
Journal:  Steroids       Date:  2004-04       Impact factor: 2.668

10.  Preferred orientations in the binding of 4'-hydroxyacetanilide (acetaminophen) to cytochrome P450 1A1 and 2B1 isoforms as determined by 13C- and 15N-NMR relaxation studies.

Authors:  T G Myers; K E Thummel; T F Kalhorn; S D Nelson
Journal:  J Med Chem       Date:  1994-03-18       Impact factor: 7.446

View more
  12 in total

1.  Production of 1-Dodecanol, 1-Tetradecanol, and 1,12-Dodecanediol through Whole-Cell Biotransformation in Escherichia coli.

Authors:  Shan-Chi Hsieh; Jung-Hao Wang; Yu-Chen Lai; Ching-Yeuh Su; Kung-Ta Lee
Journal:  Appl Environ Microbiol       Date:  2018-01-31       Impact factor: 4.792

2.  Selectivity-Determining Steps in O2 Reduction Catalyzed by Iron(tetramesitylporphyrin).

Authors:  Anna C Brezny; Samantha I Johnson; Simone Raugei; James M Mayer
Journal:  J Am Chem Soc       Date:  2020-02-20       Impact factor: 15.419

3.  A Promiscuous Cytochrome P450 Hydroxylates Aliphatic and Aromatic C-H Bonds of Aromatic 2,5-Diketopiperazines.

Authors:  Guangde Jiang; Yi Zhang; Magan M Powell; Sarah M Hylton; Nicholas W Hiller; Rosemary Loria; Yousong Ding
Journal:  Chembiochem       Date:  2019-03-27       Impact factor: 3.164

4.  Clobetasol Propionate Is a Heme-Mediated Selective Inhibitor of Human Cytochrome P450 3A5.

Authors:  William C Wright; Jude Chenge; Jingheng Wang; Hazel M Girvan; Lei Yang; Sergio C Chai; Andrew D Huber; Jing Wu; Peter O Oladimeji; Andrew W Munro; Taosheng Chen
Journal:  J Med Chem       Date:  2020-01-22       Impact factor: 7.446

5.  Substrate-Specific Allosteric Effects on the Enhancement of CYP17A1 Lyase Efficiency by Cytochrome b5.

Authors:  Yilin Liu; Ilia G Denisov; Stephen G Sligar; James R Kincaid
Journal:  J Am Chem Soc       Date:  2021-03-03       Impact factor: 15.419

6.  P450 CYP17A1 Variant with a Disordered Proton Shuttle Assembly Retains Peroxo-Mediated Lyase Efficiency.

Authors:  Yilin Liu; Ilia G Denisov; Yelena V Grinkova; Stephen G Sligar; James R Kincaid
Journal:  Chemistry       Date:  2020-11-09       Impact factor: 5.236

7.  Increased Phenacetin Oxidation upon the L382V Substitution in Cytochrome P450 1A2 is Associated with Altered Substrate Binding Orientation.

Authors:  Qingbiao Huang; Grazyna D Szklarz
Journal:  Int J Mol Sci       Date:  2018-05-25       Impact factor: 5.923

Review 8.  Mechanisms of catalytic reduction of CO2 with heme and nonheme metal complexes.

Authors:  Shunichi Fukuzumi; Yong-Min Lee; Hyun S Ahn; Wonwoo Nam
Journal:  Chem Sci       Date:  2018-07-02       Impact factor: 9.825

Review 9.  Bacterial steroid hydroxylases: enzyme classes, their functions and comparison of their catalytic mechanisms.

Authors:  Maciej Szaleniec; Agnieszka M Wojtkiewicz; Rita Bernhardt; Tomasz Borowski; Marina Donova
Journal:  Appl Microbiol Biotechnol       Date:  2018-07-21       Impact factor: 4.813

10.  Synthesis, Optimization, Antifungal Activity, Selectivity, and CYP51 Binding of New 2-Aryl-3-azolyl-1-indolyl-propan-2-ols.

Authors:  Nicolas Lebouvier; Fabrice Pagniez; Young Min Na; Da Shi; Patricia Pinson; Mathieu Marchivie; Jean Guillon; Tarek Hakki; Rita Bernhardt; Sook Wah Yee; Claire Simons; Marie-Pierre Lézé; Rolf W Hartmann; Angélique Mularoni; Guillaume Le Baut; Isabelle Krimm; Ruben Abagyan; Patrice Le Pape; Marc Le Borgne
Journal:  Pharmaceuticals (Basel)       Date:  2020-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.